{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:36:51Z","timestamp":1783784211858,"version":"3.55.0"},"reference-count":195,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FCT\u2014Portuguese Foundation for Science and Technology","award":["UID\/04033\/2025"],"award-info":[{"award-number":["UID\/04033\/2025"]}]},{"name":"FCT\u2014Portuguese Foundation for Science and Technology","award":["LA\/P\/0126\/2020"],"award-info":[{"award-number":["LA\/P\/0126\/2020"]}]},{"name":"FCT\u2014Portuguese Foundation for Science and Technology","award":["2024.15387.PEX"],"award-info":[{"award-number":["2024.15387.PEX"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Prostate cancer (PCa) remains one of the most prevalent malignancies in men and a leading cause of cancer-related mortality worldwide. Over the last century, PCa modelling has evolved from basic cell-based to more complex systems. Despite this, the clinical translation of research findings is limited by the constraints of current preclinical models. In this review, rat and zebrafish models are highlighted due to their long-standing and emerging translational relevance, respectively. Rat models have played a pivotal role in understanding carcinogenesis and supporting the preclinical evaluation of drugs currently approved for clinical use, such as antiandrogens and androgen-deprivation agents. In parallel, zebrafish models are increasingly recognized as powerful complementary tools for studying tumor biology, metastasis, and drug response, offering unique advantages for high-throughput and personalized medicine approaches. We summarize historical milestones, current advances, and translational perspectives, emphasizing how combining multiple model systems can bridge the gap between molecular research and clinical application. Collectively, the development and refinement of these models represent essential steps toward more predictive and ethically responsible PCa research.<\/jats:p>","DOI":"10.3390\/life16010111","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:27:12Z","timestamp":1768296432000},"page":"111","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In Vivo Prostate Cancer Modelling: From the Pre-Clinical to the Clinical Setting"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6430-1513","authenticated-orcid":false,"given":"Elisabete","family":"Nascimento-Gon\u00e7alves","sequence":"first","affiliation":[{"name":"Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Institute for Innovation, Capacity Building and Sustainability of Agri-Food Production (Inov4Agro), University of Tr\u00e1s-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3030-4510","authenticated-orcid":false,"given":"Tiago","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Institute for Innovation, Capacity Building and Sustainability of Agri-Food Production (Inov4Agro), University of Tr\u00e1s-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2706-7023","authenticated-orcid":false,"given":"Catarina","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Institute for Innovation, Capacity Building and Sustainability of Agri-Food Production (Inov4Agro), University of Tr\u00e1s-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5572-6317","authenticated-orcid":false,"given":"Ana I.","family":"Faustino-Rocha","sequence":"additional","affiliation":[{"name":"Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Institute for Innovation, Capacity Building and Sustainability of Agri-Food Production (Inov4Agro), University of Tr\u00e1s-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal"},{"name":"Department of Zootechnics, School of Sciences and Technology, University of \u00c9vora, 7004-516 \u00c9vora, Portugal"},{"name":"Comprehensive Health Research Center (CHRC), University of \u00c9vora, 7004-516 \u00c9vora, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12957-025-03733-1","article-title":"Global Burden of Prostate Cancer: Age-Period-Cohort Analysis from 1990 to 2021 and Projections until 2040","volume":"23","author":"Chu","year":"2025","journal-title":"World J. Surg. Oncol."},{"key":"ref_2","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA. Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"126614","DOI":"10.1016\/j.saa.2025.126614","article-title":"Prostate Cancer Detection with Blood Serum Autofluorescence: Comparison to Non-Optical Methods","volume":"343","author":"Nurgalieva","year":"2025","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., and Mashele, S. (2022). Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules, 27.","DOI":"10.3390\/molecules27175730"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Matsushita, M., Fujita, K., and Nonomura, N. (2020). Influence of Diet and Nutrition on Prostate Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041447"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","article-title":"Genomic and Phenotypic Heterogeneity in Prostate Cancer","volume":"18","author":"Haffner","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/1008-682X.178852","article-title":"Clinical Variability and Molecular Heterogeneity in Prostate Cancer","volume":"18","author":"Shoag","year":"2016","journal-title":"Asian J. Androl."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.semnuclmed.2016.07.002","article-title":"Diagnostic and Therapeutic Strategies for Prostate Cancer","volume":"46","author":"Borre","year":"2016","journal-title":"Semin. Nucl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wang, Y., Chen, Y., and Wang, J. (2025). Role of Tumor Microenvironment in Prostate Cancer Immunometabolism. Biomolecules, 15.","DOI":"10.3390\/biom15060826"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yoon, C.E., Kang, S., Rhew, S.A., Kwon, H.J., Shin, D., Moon, H.W., Kim, M.Y., and Lee, J.Y. (2025). Genetic Alterations of Prostate Cancer: In Localized and Metastatic Prostate Cancer. BMC Urol., 25.","DOI":"10.1186\/s12894-025-01840-5"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41597-025-04758-7","article-title":"A Clinical Prostate Biopsy Dataset with Undetected Cancer","volume":"12","author":"Chelebian","year":"2025","journal-title":"Sci. Data"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41585-022-00677-z","article-title":"Experimental in vitro, ex vivo and in vivo Models in Prostate Cancer Research","volume":"20","author":"Sailer","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Che, J., Liu, Y., Liu, Y., Song, J., Cui, H., Feng, D., Tian, A., Zhang, Z., and Xu, Y. (2025). The Application of Emerging Immunotherapy in the Treatment of Prostate Cancer: Progress, Dilemma and Promise. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1544882"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.3390\/curroncol29070400","article-title":"Emerging Biomarker-Guided Therapies in Prostate Cancer","volume":"29","author":"Deluce","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhu, S., Chen, J., and Zeng, H. (2023). Our Current Understanding of the Heterogeneity in Prostate Cancer and Renal Cell Carcinoma. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041526"},{"key":"ref_16","first-page":"100164","article-title":"Emerging Treatments for Metastatic Castration-Resistant Prostate Cancer: Immunotherapy, PARP Inhibitors, and PSMA-Targeted Approaches","volume":"23","author":"Marshall","year":"2020","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tzelepi, V. (2022). Prostate Cancer: Pathophysiology, Pathology and Therapy. Cancers, 15.","DOI":"10.3390\/cancers15010281"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sedelaar, J.M., and Schalken, J.A. (2015). The Need for a Personalized Approach for Prostate Cancer Management. BMC Med., 13.","DOI":"10.1186\/s12916-015-0344-1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"a030635","DOI":"10.1101\/cshperspect.a030635","article-title":"Treatment of Advanced Prostate Cancer\u2014A Review of Current Therapies and Future Promise","volume":"8","author":"Sumanasuriya","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Bahmad, H.F., Demus, T., Moubarak, M.M., Daher, D., Alvarez Moreno, J.C., Polit, F., Lopez, O., Merhe, A., Abou-Kheir, W., and Nieder, A.M. (2022). Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing. Med. Sci., 10.","DOI":"10.3390\/medsci10010015"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1002\/pros.24354","article-title":"Future Directions for Precision Oncology in Prostate Cancer","volume":"82","author":"Mizuno","year":"2022","journal-title":"Prostate"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Basak, D., Gregori, L., Johora, F., and Deb, S. (2022). Preclinical and Clinical Research Models of Prostate Cancer: A Brief Overview. Life, 12.","DOI":"10.3390\/life12101607"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14440\/jbm.2015.63","article-title":"In vitro and in vivo Model Systems Used in Prostate Cancer Research","volume":"2","author":"Cunningham","year":"2015","journal-title":"J. Biol. Methods"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Namekawa, T., Ikeda, K., Horie-Inoue, K., and Inoue, S. (2019). Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells. Cells, 8.","DOI":"10.3390\/cells8010074"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1158\/0008-5472.CAN-12-4213","article-title":"Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee","volume":"73","author":"Ittmann","year":"2013","journal-title":"Cancer Res."},{"key":"ref_26","first-page":"445","article-title":"Successful Hormonal and Chemical Induction of Prostate Cancer in a Rat Model: Practical Guidelines","volume":"15","author":"Seixas","year":"2024","journal-title":"Vet. Res. Forum"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"782","DOI":"10.5455\/OVJ.2023.v13.i6.13","article-title":"In Vivo Prostate Cancer Research: Key Interspecies Prostate Anatomical Features for Translation Medicine","volume":"13","author":"Seixas","year":"2023","journal-title":"Open Vet. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11357-023-00806-5","article-title":"Lifelong Exercise Training Promotes the Remodelling of the Immune System and Prostate Signalome in a Rat Model of Prostate Carcinogenesis","volume":"46","author":"Seixas","year":"2023","journal-title":"GeroScience"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sun, L., Zhou, Y., Yin, M., Wang, F., and Yang, L. (2025). Approaches to Modeling Cancer Metastasis: From Bench to Bedside. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1602489"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.lfs.2018.04.014","article-title":"Modelling Human Prostate Cancer: Rat Models","volume":"203","author":"Seixas","year":"2018","journal-title":"Life Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1080\/17460441.2021.1943354","article-title":"An Overview of the Latest in State-of-the-Art Murine Models for Prostate Cancer","volume":"16","author":"Seixas","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0261192920929701","article-title":"An Overview of Current Alternative Models for Use in the Context of Prostate Cancer Research","volume":"48","author":"Ferreira","year":"2020","journal-title":"Altern. Lab. Anim."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.21873\/anticanres.16167","article-title":"Evolution of Models of Prostate Cancer: Their Contribution to Current Therapies","volume":"43","author":"Oliveira","year":"2023","journal-title":"Anticancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jiang, L., Khawaja, H., Tahsin, S., Clarkson, T.A., Miranti, C.K., and Zohar, Y. (2024). Microfluidic-Based Human Prostate-Cancer-on-Chip. Front. Bioeng. Biotechnol., 12.","DOI":"10.3389\/fbioe.2024.1302223"},{"key":"ref_35","first-page":"731","article-title":"Production of Tumors of the Prostate of the White Rat with 1:2-Benzpyrene","volume":"30","author":"Moore","year":"1937","journal-title":"Am. J. Cancer"},{"key":"ref_36","first-page":"256","article-title":"Methylcholanthrene Squamous Cell Carcinoma of the Rat Prostate with Skeletal Metastases, and Failure of the Rat Liver to Respond to the Same Carcinogen","volume":"6","author":"Dunning","year":"1946","journal-title":"Cancer Res."},{"key":"ref_37","first-page":"103","article-title":"Chemical and Hormonal Induction of Prostate Cancer in Animal Models","volume":"2","author":"Bosland","year":"1996","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jcb.240501221","article-title":"Animal Models for the Study of Prostate Carcinogenesis","volume":"50","author":"Bosland","year":"1992","journal-title":"J. Cell. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.21873\/anticanres.16160","article-title":"Appraising Animal Models of Prostate Cancer for Translational Research: Future Directions","volume":"43","author":"Seixas","year":"2023","journal-title":"Anticancer Res."},{"key":"ref_40","first-page":"115","article-title":"The LNCaP Cell Line--a New Model for Studies on Human Prostatic Carcinoma","volume":"37","author":"Horoszewicz","year":"1980","journal-title":"Prog. Clin. Biol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.ju.0000141580.30910.57","article-title":"Cell Lines Used in Prostate Cancer Research: A Compendium of Old and New Lines\u2014Part 1","volume":"173","author":"Sobel","year":"2005","journal-title":"J. Urol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e00098","DOI":"10.1002\/adtp.202500098","article-title":"Microphysiological Systems in Cancer Research: Advancing Immunotherapy through Tumor Microenvironment-Integrated Organ-On-Chip Models","volume":"8","author":"Moresi","year":"2025","journal-title":"Adv. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor Microenvironment as a Therapeutic Target in Cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/pros.2990110210","article-title":"Transplantable Human Prostatic Carcinoma (PC-82) in Athymic Nude Mice: I. Hormone Dependence and the Concentration of Androgens in Plasma and Tumor Tissue","volume":"11","author":"Reuvers","year":"1987","journal-title":"Prostate"},{"key":"ref_45","first-page":"1055","article-title":"Development of Seven New Human Prostate Tumor Xenograft Models and Their Histopathological Characterization","volume":"149","author":"Verdaasdonk","year":"1996","journal-title":"Am. J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/biology3020345","article-title":"Advanced Cell Culture Techniques for Cancer Drug Discovery","volume":"3","author":"Lovitt","year":"2014","journal-title":"Biology"},{"key":"ref_47","first-page":"910","article-title":"2D and 3D Cell Cultures\u2014A Comparison of Different Types of Cancer Cell Cultures","volume":"14","author":"Kolenda","year":"2018","journal-title":"Arch. Med. Sci. AMS"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0360-3016(84)90343-2","article-title":"Binding of Misonidazole to V79 Spheroids and Fragments of Dunning Rat Prostatic and Human Colon Carcinomas in vitro: Diffusion of Oxygen and Reactive Metabolites","volume":"10","author":"Franko","year":"1984","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_49","first-page":"3171s","article-title":"Growth and Characterization of LNCaP Prostate Cancer Cell Spheroids","volume":"5","author":"Ballangrud","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","article-title":"Tumor Organoids as a Pre-Clinical Cancer Model for Drug Discovery","volume":"24","author":"Weeber","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.gene.2018.11.058","article-title":"Bioengineering-Inspired Three-Dimensional Culture Systems: Organoids to Create Tumor Microenvironment","volume":"686","year":"2019","journal-title":"Gene"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41420-025-02407-x","article-title":"Tumor Organoid-Immune Co-Culture Models: Exploring a New Perspective of Tumor Immunity","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid Cultures Derived from Patients with Advanced Prostate Cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.91.23.11236","article-title":"Prostate and Mammary Adenocarcinoma in Transgenic Mice Carrying a Rat C3(1) Simian Virus 40 Large Tumor Antigen Fusion Gene","volume":"91","author":"Maroulakou","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","first-page":"145","article-title":"The Role of PTEN in the Progression and Survival of Prostate Cancer","volume":"28","author":"Deocampo","year":"2003","journal-title":"Minerva Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/1235","article-title":"Pten is Essential for Embryonic Development and Tumour Suppression","volume":"19","author":"Cristofano","year":"1998","journal-title":"Nat. Genet."},{"key":"ref_57","first-page":"4693","article-title":"Prostate Carcinomas Developing in Transgenic Rats with SV40 T Antigen Expression under Probasin Promoter Control Are Strictly Androgen Dependent","volume":"61","author":"Asamoto","year":"2001","journal-title":"Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/dvdy.24093","article-title":"The Chick Embryo as an Expanding Experimental Model for Cancer and Cardiovascular Research","volume":"243","author":"Kain","year":"2014","journal-title":"Dev. Dyn."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0022-5347(05)65820-X","article-title":"Chorioallantoic Membrane Assay: Vascularized 3-Dimensional Cell Culture System for Human Prostate Cancer Cells as an Animal Substitute Model","volume":"166","author":"Genze","year":"2001","journal-title":"J. Urol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4013","article-title":"Neutrophil-mediated Experimental Metastasis Is Enhanced by VEGFR Inhibition in a Zebrafish Xenograft Model","volume":"227","author":"He","year":"2012","journal-title":"J. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Szewczyk, K., Jiang, L., Khawaja, H., Miranti, C.K., and Zohar, Y. (2024). Microfluidic Applications in Prostate Cancer Research. Micromachines, 15.","DOI":"10.3390\/mi15101195"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"064116","DOI":"10.1063\/1.5126714","article-title":"Human Stroma and Epithelium Co-Culture in a Microfluidic Model of a Human Prostate Gland","volume":"13","author":"Jiang","year":"2019","journal-title":"Biomicrofluidics"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Dolega, M.E., Wagh, J., Gerbaud, S., Kermarrec, F., Alcaraz, J.-P., Martin, D.K., Gidrol, X., and Picollet-D\u2019hahan, N. (2014). Facile Bench-Top Fabrication of Enclosed Circular Microchannels Provides 3D Confined Structure for Growth of Prostate Epithelial Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099416"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41392-025-02267-y","article-title":"Current Landscape of Innovative Drug Development and Regulatory Support in China","volume":"10","author":"Tan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/2159-8290.CD-20-1301","article-title":"The Future of Clinical Trials Design in Oncology","volume":"11","author":"Spreafico","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"van Rijt, A., Stefanek, E., and Valente, K. (2023). Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches. Cancers, 15.","DOI":"10.20944\/preprints202308.0109.v1"},{"key":"ref_67","unstructured":"(2025, October 06). Drugs Approved for Prostate Cancer, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/prostate."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1172\/JCI110940","article-title":"Effect of Very High Dose D-Leucine6-Gonadotropin-Releasing Hormone Proethylamide on the Hypothalamic-Pituitary Testicular Axis in Patients with Prostatic Cancer","volume":"71","author":"Warner","year":"1983","journal-title":"J. Clin. Investig."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-5347(17)50394-8","article-title":"Effects of the Gonadotropin-Releasing Hormone Agonist [D-Leu6, Desgly-NH210, Proethylamide9]-GnRH (Leuprolide) on R3327-G Rat Prostatic Tumor Growth","volume":"131","author":"Pollack","year":"1984","journal-title":"J. Urol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1095\/biolreprod30.3.646","article-title":"Effects of Chronic D-Leu6, Des-Gly10-Gonadotropin Releasing Hormone Ethylamide on Male Sex Tissues","volume":"30","author":"Rajfer","year":"1984","journal-title":"Biol. Reprod."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/endo-94-2-532","article-title":"On the Mechanism of the Anti-Androgenic Action of Flutamide (Alpha-Alpha-Alpha-Trifluoro-2-Methyl-4\u2032-Nitro-m-Propionotoluidide) in the Rat","volume":"94","author":"Peets","year":"1974","journal-title":"Endocrinology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1210\/endo-94-4-1205","article-title":"Action of a Nonsteroidal Antiandrogen, Flutamide, on the Receptor Binding and Nuclear Retention of 5 Alpha-Dihydrotestosterone in Rat Ventral Prostate","volume":"94","author":"Liao","year":"1974","journal-title":"Endocrinology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0015-0282(16)41840-6","article-title":"Studies on the Physiology and Biochemistry of Mammalian Epididymis: Effect of Flutamide, a Nonsteroidal Antiandrogen, on the Epididymis of the Rat","volume":"27","author":"Dhar","year":"1976","journal-title":"Fertil. Steril."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1464-410X.1977.tb04555.x","article-title":"The Effect of Antiandrogens and Stilboestrol on the Cytosol Receptor in Rat Prostate","volume":"49","author":"Ghanadian","year":"1977","journal-title":"Br. J. Urol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/bst0070565","article-title":"Anti-Androgenicity of Flutamide and Its Metabolite Sch 16423","volume":"7","author":"Neri","year":"1979","journal-title":"Biochem. Soc. Trans."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1210\/endo-106-6-1917","article-title":"Flutamide Inhibits Testosterone-Induced Masculine Sexual Behavior in Male and Female Rats","volume":"106","author":"Gladue","year":"1980","journal-title":"Endocrinology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1210\/endo-109-3-830","article-title":"Response of Rat Ventral Prostate to a New and Novel 5 Alpha-Reductase Inhibitor","volume":"109","author":"Brooks","year":"1981","journal-title":"Endocrinology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1439-0272.1982.tb03120.x","article-title":"Involvement of Lysosomal Enzymes in Flutamide-Induced Stimulation of Rat Testis","volume":"14","author":"Mathur","year":"1982","journal-title":"Andrologia"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/j.1939-4640.1983.tb00739.x","article-title":"Influence of Estradiol on Accessory Reproductive Organs in the Castrated Male Rat. Effects of Bromocriptine and Flutamide","volume":"4","author":"Belis","year":"1983","journal-title":"J. Androl."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/pros.2990050604","article-title":"Action of Prolactin in Regressing Prostate: Independent of Action Mediated by Androgen Receptors","volume":"5","author":"Assimos","year":"1984","journal-title":"Prostate"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1210\/endo-114-6-2183","article-title":"Androgens Regulate Brain Aromatase Activity in Adult Male Rats through a Receptor Mechanism","volume":"114","author":"Roselli","year":"1984","journal-title":"Endocrinology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0303-7207(84)90047-9","article-title":"Anti-Androgens Do Not Alter Androgen-Dependent Characteristics of Acid Phosphatase in the Rat Ventral Prostate","volume":"37","author":"Tenniswood","year":"1984","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/pros.2990060302","article-title":"Investigation of the Combination of the Agonist D-Trp-6-LH-RH and the Antiandrogen Flutamide in the Treatment of Dunning R-3327H Prostate Cancer Model","volume":"6","author":"Redding","year":"1985","journal-title":"Prostate"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/pros.2990090303","article-title":"Role of Adrenal Androgens in Prostate Regression in Rats Treated with an Antiandrogen and an LHRH Agonist","volume":"9","author":"Foldesy","year":"1986","journal-title":"Prostate"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0022-5347(17)45134-2","article-title":"Effectiveness of Antiandrogens in the Rat","volume":"136","author":"Burton","year":"1986","journal-title":"J. Urol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pros.2990110408","article-title":"Effect of Cyproterone Acetate in Comparison to Flutamide and Megestrol Acetate on the Ventral Prostate, Seminal Vesicle, and Adrenal Glands of Adult Male Rats","volume":"11","author":"Habenicht","year":"1987","journal-title":"Prostate"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1677\/joe.0.113R007","article-title":"ICI 176,334: A Novel Non-Steroidal, Peripherally Selective Antiandrogen","volume":"113","author":"Furr","year":"1987","journal-title":"J. Endocrinol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/0006-2952(87)90004-9","article-title":"Effect of Flutamide on Hepatic Cytosolic Methyltrienolone (R1881) Binding Kinetics and Testosterone Responsive Hepatic Drug and Steroid Metabolism in the Adult Male Rat","volume":"36","author":"Sunahara","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/pros.2990130205","article-title":"Treatment with Antiandrogens Induces an Androgen-Repressed Gene in the Rat Ventral Prostate","volume":"13","author":"Tenniswood","year":"1988","journal-title":"Prostate"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/pros.2990120409","article-title":"Effect of Adrenalectomy, Flutamide, and Leuprolide on the Growth of the Dunning Rat R-3327 Prostatic Carcinoma","volume":"12","author":"Kung","year":"1988","journal-title":"Prostate"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0022-5347(17)42914-4","article-title":"Relative Effectiveness of Alternative Androgen Withdrawal Therapies in Initiating Regression of Rat Prostate","volume":"139","author":"Rennie","year":"1988","journal-title":"J. Urol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1677\/jme.0.0010213","article-title":"Effects of Sex Steroids on Regulation of the Levels of C1 Peptide of Rat Prostatic Steroid-Binding Protein mRNA Evaluated by in-Situ Hybridization","volume":"1","author":"Pelletier","year":"1988","journal-title":"J. Mol. Endocrinol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1021\/jm00400a011","article-title":"Nonsteroidal Antiandrogens. Synthesis and Structure-Activity Relationships of 3-Substituted Derivatives of 2-Hydroxypropionanilides","volume":"31","author":"Tucker","year":"1988","journal-title":"J. Med. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/bjc.1989.336","article-title":"A Possible Explanation for the Peripheral Selectivity of a Novel Non-Steroidal Pure Antiandrogen, Casodex (ICI 176,334)","volume":"60","author":"Freeman","year":"1989","journal-title":"Br. J. Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0022-4731(89)90419-6","article-title":"Endocrine Profile of Win 49596 in the Rat: A Novel Androgen Receptor Antagonist","volume":"33","author":"Snyder","year":"1989","journal-title":"J. Steroid Biochem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/BF01215986","article-title":"Antiproliferative Activity of Casodex (ICI 176.334) in Hormone-Dependent Tumours","volume":"119","author":"Maucher","year":"1993","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/pros.2990250205","article-title":"Androgen Ablation Induces Tenascin Expression in the Rat Prostate","volume":"25","author":"Vollmer","year":"1994","journal-title":"Prostate"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/jnci\/87.11.842","article-title":"Chemoprevention of Rat Prostate Carcinogenesis by Use of Finasteride or Casodex","volume":"87","author":"Tsukamoto","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0303-7207(81)90028-9","article-title":"Additive Inhibitory Effects of Treatment with an LHRH Agonist and an Antiandrogen on Androgen-Dependent Tissues in the Rat","volume":"21","author":"Cusan","year":"1981","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/pros.2990050307","article-title":"The Pure Antiandrogen RU 23908 (Anandron), a Candidate of Choice for the Combined Antihormonal Treatment of Prostatic Cancer: A Review","volume":"5","author":"Raynaud","year":"1984","journal-title":"Prostate"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0022-4731(86)90043-9","article-title":"Pharmacology of an Antiandrogen, Anandron, Used as an Adjuvant Therapy in the Treatment of Prostate Cancer","volume":"24","author":"Moguilewsky","year":"1986","journal-title":"J. Steroid Biochem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0022-4731(87)90162-2","article-title":"Pharmacological and Clinical Studies of the Antiandrogen Anandron","volume":"27","author":"Moguilewsky","year":"1987","journal-title":"J. Steroid Biochem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/00000421-198801102-00035","article-title":"The Antiandrogen Anandron Potentiates the Castrating Effect of the LH-RH Agonist Buserelin in the Rat","volume":"11","author":"Moguilewsky","year":"1988","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/pros.2990130108","article-title":"Efficacy and Advantages in the Use of Low Doses of Anandron and Estrogen Combination in the Treatment of Prostate Cancer","volume":"13","author":"Rao","year":"1988","journal-title":"Prostate"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0022-4731(88)90024-6","article-title":"Merits and Considerations in the Use of Anti-Androgen","volume":"31","author":"Rao","year":"1988","journal-title":"J. Steroid Biochem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/07435809009033002","article-title":"Changes in Testis, Epididymis and Other Accessory Organs of Male Rats Treated with Anandron during Sexual Maturation","volume":"16","author":"Dhar","year":"1990","journal-title":"Endocr. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0010-7824(90)90096-E","article-title":"Effect of a Nonsteroidal Antiandrogen, Anandron, on the Reproductive System and Fertility in Male Rats","volume":"42","author":"Dhar","year":"1990","journal-title":"Contraception"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0090-4295(91)80096-P","article-title":"Pharmacokinetics and Metabolism of Nilutamide","volume":"37","author":"Creaven","year":"1991","journal-title":"Urology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0090-4295(91)80095-O","article-title":"Pharmacology of Antiandrogens and Value of Combining Androgen Suppression with Antiandrogen Therapy","volume":"37","year":"1991","journal-title":"Urology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0167-4889(91)90031-R","article-title":"Effects of Steroidal and Non-Steroidal Antiandrogens on the Androgen Binding Properties of the Rat Ventral Prostate Androgen Receptor","volume":"1094","author":"Steinsapir","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0024-3205(81)90369-6","article-title":"Inhibition of the Action of Sex Steroids by Gonadotropin-Releasing Hormone (GnRH) Agonists: A New Biological Effect","volume":"28","author":"Sundaram","year":"1981","journal-title":"Life Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1073\/pnas.78.10.6509","article-title":"Inhibition of Prostate Tumor Growth in Two Rat Models by Chronic Administration of D-Trp6 Analogue of Luteinizing Hormone-Releasing Hormone","volume":"78","author":"Redding","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/pros.2990040602","article-title":"Inhibition of Prostate Tumors by Agonistic and Antagonistic Analogs of LH-RH","volume":"4","author":"Schally","year":"1983","journal-title":"Prostate"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/pros.2990050606","article-title":"Endogenous Phosphorylation in Dunning Prostate Tumors of Rats Treated with LH-RH Analogues","volume":"5","author":"Cehovic","year":"1984","journal-title":"Prostate"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02934982","article-title":"Inhibition of the Growth of Some Hormone Dependent Tumors by D-Trp6-LH-RH","volume":"1","author":"Schally","year":"1984","journal-title":"Med. Oncol. Tumor Pharmacother."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1073\/pnas.81.18.5845","article-title":"Long-Acting Delivery Systems for Peptides: Inhibition of Rat Prostate Tumors by Controlled Release of [D-Trp6]Luteinizing Hormone-Releasing Hormone from Injectable Microcapsules","volume":"81","author":"Redding","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000180036","article-title":"An Inhibitor of Urokinase and Tissue Plasminogen Activators in Dunning R3327H Prostate Tumors of Rats Treated with D-Trp6-LH-RH","volume":"21","author":"Hierowski","year":"1985","journal-title":"Horm. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1073\/pnas.82.8.2498","article-title":"Combination of Long-Acting Microcapsules of the D-Tryptophan-6 Analog of Luteinizing Hormone-Releasing Hormone with Chemotherapy: Investigation in the Rat Prostate Cancer Model","volume":"82","author":"Schally","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0167-0115(86)90216-8","article-title":"Radioimmunoassay of [D-Trp6]-Luteinizing Hormone-Releasing Hormone: Its Application to Animal Pharmacokinetic Studies after Single Injection and Long-Acting Formulation Administration","volume":"14","author":"Ezan","year":"1986","journal-title":"Regul. Pept."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"8764","DOI":"10.1073\/pnas.83.22.8764","article-title":"Combination of a Long-Acting Delivery System for Luteinizing Hormone-Releasing Hormone Agonist with Novantrone Chemotherapy: Increased Efficacy in the Rat Prostate Cancer Model","volume":"83","author":"Schally","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pros.2990100403","article-title":"Histological Findings in the Rat Prostate Cancer Model during Treatment with a Luteinizing Hormone-Releasing Hormone Agonist and Novantrone","volume":"10","author":"Schor","year":"1987","journal-title":"Prostate"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1073\/pnas.84.20.7275","article-title":"Somatostatin Analogs as Adjuncts to Agonists of Luteinizing Hormone-Releasing Hormone in the Treatment of Experimental Prostate Cancer","volume":"84","author":"Schally","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/pros.2990120111","article-title":"Histologic Changes in the Rat Prostate Cancer Model after Treatment with Somatostatin Analogs and D-Trp-6-LH-RH","volume":"12","author":"Zalatnai","year":"1988","journal-title":"Prostate"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1073\/pnas.85.3.890","article-title":"Receptors for Prolactin, Somatostatin, and Luteinizing Hormone-Releasing Hormone in Experimental Prostate Cancer after Treatment with Analogs of Luteinizing Hormone-Releasing Hormone and Somatostatin","volume":"85","author":"Kadar","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0022-4731(88)90170-7","article-title":"Characteristics of Flutamide Action on Prostatic and Testicular Functions in the Rat","volume":"29","author":"Marchetti","year":"1988","journal-title":"J. Steroid Biochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/mend-2-9-775","article-title":"Modulation by Sex Steroids and [D-Trp6, Des-Gly-NH2(10)]Luteinizing Hormone (LH)-Releasing Hormone Ethylamide of Alpha-Subunit and LH Beta Messenger Ribonucleic Acid Levels in the Rat Anterior Pituitary Gland","volume":"2","author":"Simard","year":"1988","journal-title":"Mol. Endocrinol. Baltim. Md."},{"key":"ref_127","first-page":"1273","article-title":"Decrease in the AgNOR Number in Dunning R3327 Prostate Cancers after Treatment with an Agonist and Antagonist of Luteinizing Hormone-Releasing Hormone","volume":"138","author":"Szepeshazi","year":"1991","journal-title":"Am. J. Pathol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/pros.2990200306","article-title":"Blockade of the LH Response Induced by the Agonist D-Trp-6-LHRH in Rats by a Highly Potent LH-RH Antagonist SB-75","volume":"20","author":"Pinski","year":"1992","journal-title":"Prostate"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijc.2910590112","article-title":"Inhibitory Effects of Analogs of Luteinizing Hormone-Releasing Hormone on the Growth of the Androgen-Independent Dunning R-3327-AT-1 Rat Prostate Cancer","volume":"59","author":"Pinski","year":"1994","journal-title":"Int. J. Cancer"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejpb.2004.01.005","article-title":"Biodegradable PLGA Microparticles for Sustained Release of a New GnRH Antagonist: Part II. In Vivo Performance","volume":"57","author":"Schwach","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1124\/jpet.106.112326","article-title":"Rapid Suppression of Plasma Testosterone Levels and Tumor Growth in the Dunning Rat Model Treated with Degarelix, a New Gonadotropin-Releasing Hormone Antagonist","volume":"320","author":"Princivalle","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0960-0760(03)00078-5","article-title":"In vitro and in vivo Models for the Evaluation of Potent Inhibitors of Male Rat 17alpha-Hydroxylase\/C17,20-Lyase","volume":"84","author":"Duc","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0960-0760(03)00070-0","article-title":"Effects of Novel 17alpha-Hydroxylase\/C17, 20-Lyase (P450 17, CYP 17) Inhibitors on Androgen Biosynthesis in Vitro and in Vivo","volume":"84","author":"Haidar","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.bmcl.2017.04.071","article-title":"Design, Synthesis, and Biological Evaluation of Deuterated Apalutamide with Improved Pharmacokinetic Profiles","volume":"27","author":"Pang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Kiran, V., Dixit, A., Gabani, B.B., Srinivas, N.R., and Mullangi, R. (2020). Novel Methodology to Perform Incurred Sample Reanalysis on Dried Blood Spot Cards: Experimental Data Using Darolutamide and Filgotinib. Biomed. Chromatogr. BMC, 34.","DOI":"10.1002\/bmc.4938"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"117566","DOI":"10.1016\/j.ejmech.2025.117566","article-title":"Discovery of Novel Tetrahydroquinoline Derivatives as Potent, Selective, and Orally Available AR Antagonists","volume":"291","author":"Yuan","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/pros.2990110308","article-title":"Renewal Timing of Long-Acting Depot Luteinizing Hormone-Releasing Hormone Agonist (Zoladex) Is Critical in the Treatment of Hormone-Dependent Rat Prostatic Carcinoma (R3327-H)","volume":"11","author":"Geldof","year":"1987","journal-title":"Prostate"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1677\/joe.0.1120345","article-title":"Regeneration of the Thymus in Old Male Rats Treated with a Stable Analogue of LHRH","volume":"112","author":"Greenstein","year":"1987","journal-title":"J. Endocrinol."},{"key":"ref_139","first-page":"6063","article-title":"Rat Prostatic Weight Regression in Reaction to Ketoconazole, Cyproterone Acetate, and RU 23908 as Adjuncts to a Depot Formulation of Gonadotropin-Releasing Hormone Analogue","volume":"48","author":"Lamberts","year":"1988","journal-title":"Cancer Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/j.1939-4640.1989.tb00144.x","article-title":"Prolonged Suppression of Rat Testis Function by a Depot Formulation of Zoladex, a GnRH Agonist","volume":"10","author":"Ward","year":"1989","journal-title":"J. Androl."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.pcan.4501005","article-title":"Influence of the Docetaxel Administration Period (Neoadjuvant or Concomitant) in Relation to HIFU Treatment on the Growth of Dunning Tumors: Results of a Preliminary Study","volume":"11","author":"Paparel","year":"2008","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1200\/JCO.2010.30.7025","article-title":"Castration-Dependent Pharmacokinetics of Docetaxel in Patients with Prostate Cancer","volume":"28","author":"Franke","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The Zebrafish Reference Genome Sequence and Its Relationship to the Human Genome","volume":"496","author":"Howe","year":"2013","journal-title":"Nature"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/17460441.2017.1297416","article-title":"Zebrafish Xenograft Models of Cancer and Metastasis for Drug Discovery","volume":"12","author":"Brown","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s12094-024-03406-7","article-title":"Zebrafish Live Imaging: A Strong Weapon in Anticancer Drug Discovery and Development","volume":"26","author":"Zhan","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e70002","DOI":"10.1002\/wsbm.70002","article-title":"Biomedical Models: Use of Zebrafish as a Multi-Utility In Vivo Tool Box","volume":"17","author":"Mohanty","year":"2025","journal-title":"WIREs Mech. Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1038\/ncomms10358","article-title":"Imaging Tumour Cell Heterogeneity Following Cell Transplantation into Optically Clear Immune-Deficient Zebrafish","volume":"7","author":"Tang","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2307\/1543433","article-title":"A Three-Year Retrospective Study of Abdominal Tumors in Zebrafish Maintained in an Aquatic Laboratory Animal Facility","volume":"203","author":"Smolowitz","year":"2002","journal-title":"Biol. Bull."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0091-679X(04)77033-8","article-title":"Common Diseases of Laboratory Zebrafish","volume":"Volume 77","author":"Matthews","year":"2004","journal-title":"Methods in Cell Biology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/zeb.2009.0612","article-title":"Global Repression of Cancer Gene Expression in a Zebrafish Model of Melanoma Is Linked to Epigenetic Regulation","volume":"6","author":"Anelli","year":"2009","journal-title":"Zebrafish"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2011.07.025","article-title":"Inducible and Repressable Oncogene-Addicted Hepatocellular Carcinoma in Tet-on Xmrk Transgenic Zebrafish","volume":"56","author":"Li","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Raby, L., V\u00f6lkel, P., Le Bourhis, X., and Angrand, P.-O. (2020). Genetic Engineering of Zebrafish in Cancer Research. Cancers, 12.","DOI":"10.3390\/cancers12082168"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1158\/0008-5472.CAN-18-1029","article-title":"Zebrafish: Speeding Up the Cancer Drug Discovery Process","volume":"78","author":"Letrado","year":"2018","journal-title":"Cancer Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1535-6108(02)00052-1","article-title":"Zebrafish as a Cancer Model System","volume":"1","author":"Amatruda","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"a037077","DOI":"10.1101\/cshperspect.a037077","article-title":"Zebrafish in vivo Models of Cancer and Metastasis","volume":"10","author":"Astell","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Gamble, J.T., Elson, D.J., Greenwood, J.A., Tanguay, R.L., and Kolluri, S.K. (2021). The Zebrafish Xenograft Models for Investigating Cancer and Cancer Therapeutics. Biology, 10.","DOI":"10.3390\/biology10040252"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ntt.2012.08.006","article-title":"Zebrafish as Potential Model for Developmental Neurotoxicity Testing","volume":"34","author":"Slieker","year":"2012","journal-title":"Neurotoxicol. Teratol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.bbadis.2013.01.016","article-title":"Zebrafish Embryo as a Tool to Study Tumor\/Endothelial Cell Cross-Talk","volume":"1832","author":"Tobia","year":"2013","journal-title":"Biochim. Biophys. Acta BBA-Mol. Basis Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"124975","DOI":"10.1016\/j.envpol.2024.124975","article-title":"The Effects of Perfluorooctanoic Acid on Breast Cancer Metastasis Depend on the Phenotypes of the Cancer Cells: An in Vivo Study with Zebrafish Xenograft Model","volume":"362","author":"Huang","year":"2024","journal-title":"Environ. Pollut."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"101162","DOI":"10.1016\/j.drup.2024.101162","article-title":"Zebrafish Patient-Derived Xenograft System for Predicting Carboplatin Resistance and Metastasis of Ovarian Cancer","volume":"78","author":"Song","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"17406","DOI":"10.1073\/pnas.0703446104","article-title":"High-Resolution Imaging of the Dynamic Tumor Cell\u2013Vascular Interface in Transparent Zebrafish","volume":"104","author":"Stoletov","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1182\/blood-2004-01-0100","article-title":"Effects of Lethal Irradiation in Zebrafish and Rescue by Hematopoietic Cell Transplantation","volume":"104","author":"Traver","year":"2004","journal-title":"Blood"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.cell.2019.04.004","article-title":"Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish","volume":"177","author":"Yan","year":"2019","journal-title":"Cell"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/leu.2016.26","article-title":"The TCA Cycle Transferase DLST Is Important for MYC-Mediated Leukemogenesis","volume":"30","author":"Anderson","year":"2016","journal-title":"Leukemia"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"14698","DOI":"10.1038\/s41598-017-14413-w","article-title":"Enzalutamide Inhibits Testosterone-Induced Growth of Human Prostate Cancer Xenografts in Zebrafish and Can Induce Bradycardia","volume":"7","author":"Melong","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"116791","DOI":"10.1016\/j.lfs.2019.116791","article-title":"Cancer-Associated Fibroblast Regulate Proliferation and Migration of Prostate Cancer Cells through TGF-\u03b2 Signaling Pathway","volume":"235","author":"Sun","year":"2019","journal-title":"Life Sci."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Chen, L., Boleslaw Olszewski, M., Kruithof-de Julio, M., and Snaar-Jagalska, B.E. (2020). Zebrafish Microenvironment Elevates EMT and CSC-Like Phenotype of Engrafted Prostate Cancer Cells. Cells, 9.","DOI":"10.3390\/cells9040797"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/17460441.2024.2313454","article-title":"What Value Do Zebrafish Have to Anticancer Drug Discovery?","volume":"19","author":"Xiao","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Cornet, C., Dyballa, S., Terriente, J., and Di Giacomo, V. (2019). ZeOncoTest: Refining and Automating the Zebrafish Xenograft Model for Drug Discovery in Cancer. Pharmaceuticals, 13.","DOI":"10.3390\/ph13010001"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Fang, W., Chen, Y., Nie, M., Zhou, X., Liu, Y., Tao, H., Yang, B., and Wang, X. (2025). Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation. Mar. Drugs, 23.","DOI":"10.3390\/md23050214"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s11010-024-05026-9","article-title":"Ilicicolin C Suppresses the Progression of Prostate Cancer by Inhibiting PI3K\/AKT\/mTOR Pathway","volume":"480","author":"Gan","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"175988","DOI":"10.1016\/j.ejphar.2023.175988","article-title":"Dankasterone A Induces Prostate Cancer Cell Death by Inducing Oxidative Stress","volume":"957","author":"Gan","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1007\/s11033-022-07307-2","article-title":"Kaempferol Suppresses Androgen-Dependent and Androgen-Independent Prostate Cancer by Regulating Ki67 Expression","volume":"49","author":"Zhang","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"42438","DOI":"10.18632\/oncotarget.17124","article-title":"Discovery and Characterization of Small Molecules Targeting the DNA-Binding ETS Domain of ERG in Prostate Cancer","volume":"8","author":"Butler","year":"2017","journal-title":"Oncotarget"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41573-021-00210-8","article-title":"Zebrafish Disease Models in Drug Discovery: From Preclinical Modelling to Clinical Trials","volume":"20","author":"Patton","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Reimunde, P., Pensado-L\u00f3pez, A., Carreira Crende, M., Lombao Iglesias, V., S\u00e1nchez, L., Torrecilla-Parra, M., Ram\u00edrez, C.M., Anfray, C., and Torres And\u00f3n, F. (2021). Cellular and Molecular Mechanisms Underlying Glioblastoma and Zebrafish Models for the Discovery of New Treatments. Cancers, 13.","DOI":"10.3390\/cancers13051087"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Roy, D., Subramaniam, B., Chong, W.C., Bornhorst, M., Packer, R.J., and Nazarian, J. (2024). Zebrafish\u2014A Suitable Model for Rapid Translation of Effective Therapies for Pediatric Cancers. Cancers, 16.","DOI":"10.3390\/cancers16071361"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2174\/1568026617666170130112109","article-title":"The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation","volume":"17","author":"Yoganantharjah","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.ddtec.2012.04.006","article-title":"Zebrafish Cancer and Metastasis Models for in vivo Drug Discovery","volume":"10","author":"Tat","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Usai, A., Di Franco, G., Piccardi, M., Cateni, P., Pollina, L.E., Vivaldi, C., Vasile, E., Funel, N., Palmeri, M., and Dente, L. (2021). Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients. Cancers, 13.","DOI":"10.3390\/cancers13164131"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41698-025-00882-0","article-title":"Zebrafish Avatar Testing Preclinical Study Predicts Chemotherapy Response in Breast Cancer","volume":"9","author":"Mendes","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_182","first-page":"153","article-title":"PDX Models for Functional Precision Oncology and Discovery Science","volume":"25","author":"Blanchard","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1134\/S0026893324700031","article-title":"Zebrafish Xenographs in Oncology and Personalized Medicine","volume":"58","author":"Lunina","year":"2024","journal-title":"Mol. Biol."},{"key":"ref_184","first-page":"1041","article-title":"The Current Status of Prostate Cancer Animal Models","volume":"3","author":"Jiang","year":"2020","journal-title":"J. Vet. Med. Anim. Sci."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nhtm.2014.08.001","article-title":"Animal Models in Translational Medicine: Validation and Prediction","volume":"2","author":"Denayer","year":"2014","journal-title":"Eur. J. Mol. Clin. Med."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Richter, H., Karol, A., Nuss, K., Lenisa, A., Bruellmann, E., Maudens, S.-S., Hoffmann, H., Von Rechenberg, B., and Kircher, P.R. (2018). Comparison of Hock- and Footpad-Injection as a Prostate Adenocarcinoma Model in Rats. BMC Vet. Res., 14.","DOI":"10.1186\/s12917-018-1659-x"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Ginja, M., Pires, M.J., Gonzalo-Orden, J.M., Seixas, F., Correia-Cardoso, M., Ferreira, R., Fardilha, M., Oliveira, P.A., and Faustino-Rocha, A.I. (2019). Anatomy and Imaging of Rat Prostate: Practical Monitoring in Experimental Cancer-Induced Protocols. Diagnostics, 9.","DOI":"10.3390\/diagnostics9030068"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Saranyutanon, S., Deshmukh, S.K., Dasgupta, S., Pai, S., Singh, S., and Singh, A.P. (2020). Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research. Cancers, 12.","DOI":"10.3390\/cancers12092651"},{"key":"ref_189","first-page":"16","article-title":"Review of Animal Models of Prostate Cancer Bone Metastasis","volume":"1","author":"Simmons","year":"2014","journal-title":"Vet. Sci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/01926233221096345","article-title":"The MNU Plus Testosterone Rat Model of Prostate Carcinogenesis","volume":"50","author":"Bosland","year":"2022","journal-title":"Toxicol. Pathol."},{"key":"ref_191","first-page":"1","article-title":"Prostate Carcinoma in Transgenic Lewis Rats\u2014A Tumor Model for Evaluation of Immunological Treatments","volume":"2","author":"Johnson","year":"2013","journal-title":"Chin. Clin. Oncol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"dmm049147","DOI":"10.1242\/dmm.049147","article-title":"The Zebrafish Embryo as an in vivo Model for Screening Nanoparticle-Formulated Lipophilic Anti-Tuberculosis Compounds","volume":"15","author":"Speth","year":"2022","journal-title":"Dis. Models Mech."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Bangeppagari, M., Manjunath, A., Srinivasa, A., and Lee, S.J. (2025). Tiny Fish, Big Hope: Zebrafish Unlocking Secrets to Fight Parkinson\u2019s Disease. Biology, 14.","DOI":"10.3390\/biology14101397"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/17460441.2022.2072828","article-title":"Zebrafish for Modeling Stroke and Their Applicability for Drug Discovery and Development","volume":"17","author":"Crilly","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s12975-020-00830-z","article-title":"A Multi-Model Pipeline for Translational Intracerebral Haemorrhage Research","volume":"11","author":"Withers","year":"2020","journal-title":"Transl. Stroke Res."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/1\/111\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:35:11Z","timestamp":1768296911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/1\/111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":195,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["life16010111"],"URL":"https:\/\/doi.org\/10.3390\/life16010111","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]}}}